What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2021-08-09 compared with 2021-05-11 · 17 added, 28 removed, 3 unchanged (94% of the section changed)

OTHER INFORMATION

Certification

of Chief Executive Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

Certification

of Chief Financial Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

Certification

of Chief Executive Officer and Chief Financial Officer Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Instance Document*

Schema Document*

Calculation Linkbase Document*

Definition Linkbase Document*

Label Linkbase Document*

Presentation Linkbase Document*

______________________

Pursuant to Rule 406T of Regulation S-T, these interactive data

files are not deemed filed or part of a registration statement or

prospectus for purposes of Section 11 or 12 of the Securities Act

or Section 18 of the Securities Exchange Act and otherwise not

subject to liability.

to the requirements of Section 12 of the Securities and Exchange

Act of 1934, the Registrant has duly caused this Report to be

signed on its behalf by the undersigned, thereunto duly authorized

on May 11, 2021.

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

Inline XBRL Taxonomy Extension Schema Document

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Inline XBRL Taxonomy Extension Definition Linkbase Document

Inline XBRL Taxonomy Extension Label Linkbase Document

Inline XBRL Taxonomy Extension Presentation Linkbase Document

Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

Pursuant to the requirements

of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the

undersigned, thereunto duly authorized on August 9, 2021.

SUNSHINE BIOPHARMA, INC.

Executive Officer

Principal Executive Officer

s/ Camille Sebaaly

Camille Sebaaly,

Financial Officer and

Accounting Officer

Principal Financial Officer and

Principal Accounting Officer

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information